Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 493 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others


Rituximab in treatment of idiopathic glomerulopathy

El-Reshaid Kamel, Sallam Hossameldin Tawfik, Hakim Abbass Ali, Al-Attiyah Rajaa

Year : 2012| Volume: 23| Issue : 5 | Page no: 973-978

   This article has been cited by
1 Experience of application of rituximab with resistant focal-segmental glomerulosclerosis in adults: a series of observations and a brief review of literature
N. V. Chebotareva, A. M. Kuchieva, O. A. Lee, C. V. Roshchupkina, V. Cao
Nephrology (Saint-Petersburg). 2020; 24(2): 52
[Pubmed]  [Google Scholar] [DOI]
2 Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis
Hong Ren, Li Lin, Pingyan Shen, Xiao Li, Jingyuan Xie, Xiaoxia Pan, Wen Zhang, Nan Chen
Oncotarget. 2017; 8(55): 93438
[Pubmed]  [Google Scholar] [DOI]
3 Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review
Andreas Kronbichler,Julia Kerschbaum,Gema Fernandez-Fresnedo,Elion Hoxha,Christine E. Kurschat,Martin Busch,Annette Bruchfeld,Gert Mayer,Michael Rudnicki
American Journal of Nephrology. 2014; 39(4): 322
[Pubmed]  [Google Scholar] [DOI]
4 Rituximab for adult primary FSGS and MCD [Rituximab bei primärer FSGS und MCD im Erwachsenenalter]
Kronbichler, A. and Rudnicki, M. and Mayer, G.
Nephrologe. 2013; 8(2): 144-149
[Pubmed]  [Google Scholar]
5 Rituximab bei primärer FSGS und MCD im Erwachsenenalter
A. Kronbichler,M. Rudnicki,G. Mayer
Der Nephrologe. 2013; 8(2): 144
[Pubmed]  [Google Scholar] [DOI]


Read this article